Dataset Information

Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors.

ABSTRACT: Human epidermal growth factor receptor (EGFR) is an important drug target that plays a fundamental role in signal transduction pathways in oncology. We report herein the discovery of a novel class of phenylpiperazine derivatives with improved potency toward EGFR. The biological activity of compound 3p as inhibitor of EGFR was further investigated both in vitro and in vivo. Notably, compound 3p exhibited an IC50 in the nanomolar range in A549 cell cultures and induced a cessation of tumor growth with no toxicity, as determined by loss of body weight and death of treated mice. Compoutational docking studies also showed that compound 3p has interaction with EGFR key residues in the active site.

SUBMITTER: Sun J

PROVIDER: S-EPMC4563558 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors.

Sun Juan J Wang Xin-Yi XY Lv Peng-Cheng PC Zhu Hai-Liang HL

Scientific reports 20150909

Human epidermal growth factor receptor (EGFR) is an important drug target that plays a fundamental role in signal transduction pathways in oncology. We report herein the discovery of a novel class of phenylpiperazine derivatives with improved potency toward EGFR. The biological activity of compound 3p as inhibitor of EGFR was further investigated both in vitro and in vivo. Notably, compound 3p exhibited an IC50 in the nanomolar range in A549 cell cultures and induced a cessation of tumor growth ...[more]

PMID: 26349898

Dataset Information

Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors.

Publications

Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Similar Datasets

Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors.
| S-EPMC6993756 | biostudies-literature

Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors.
| S-EPMC6232652 | biostudies-literature

A New Series of Indeno[1,2-<i>c</i>]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy.
| S-EPMC8778314 | biostudies-literature

Discovery of aminopyridine-containing spiro derivatives as EGFR mutations inhibitors.
| S-EPMC6691816 | biostudies-literature

Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity.
| S-EPMC5554905 | biostudies-literature

Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors.
| S-EPMC5943947 | biostudies-literature

Discovery of a Series of Thiazole Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration and Invasion.
| S-EPMC3601768 | biostudies-literature

Discovery of Potent EGFR Inhibitors With <i>6-Arylureido-4-anilinoquinazoline</i> Derivatives.
| S-EPMC8187944 | biostudies-literature

Structure-Based Drug Design Studies Toward the Discovery of Novel Chalcone Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors.
| S-EPMC6321200 | biostudies-literature

Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors.
| S-EPMC4027597 | biostudies-literature